TCIM
ISEE

TIAA CREF Investment Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

TIAA CREF Investment Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-124,132
Closed -$454K – 3197
2017
Q1 		$454K Sell
124,132
-15,610
-11% -$66K ﹤0.01% 2822
2016
Q4 		$675K Buy
139,742
+338
+0.2% +$10K ﹤0.01% 2720
2016
Q3 		$6.43K Sell
139,404
-1,621
-1% -$91.4K ﹤0.01% 1431
2016
Q2 		$7.2M Buy
141,025
+19,895
+16% +$989K 0.01% 1281
2016
Q1 		$5.12M Sell
121,130
-2,107
-2% -$107K ﹤0.01% 1495
2015
Q4 		$9.68M Sell
123,237
-5,074
-4% -$293K 0.01% 1091
2015
Q3 		$5.2M Buy
128,311
+6,177
+5% +$327K ﹤0.01% 1508
2015
Q2 		$6.36M Buy
122,134
+20,428
+20% +$1.02M ﹤0.01% 1501
2015
Q1 		$4.73M Buy
101,706
+5,744
+6% +$298K ﹤0.01% 1680
2014
Q4 		$4.31M Buy
95,962
+28,799
+43% +$1.21M ﹤0.01% 1728
2014
Q3 		$2.62M Buy
67,163
+14,051
+26% +$551K ﹤0.01% 2062
2014
Q2 		$2.25M Buy
53,112
+17,758
+50% +$652K ﹤0.01% 2235
2014
Q1 		$1.26M Hold
35,354
– – ﹤0.01% 2510
2013
Q4 		$1.14M Buy
+35,354
New +$1.05M ﹤0.01% 2592

Other funds holding ISEE

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BIM
Bogle Investment Management Newton Lower Falls, Massachusetts $63M AUM 51.97% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TIAA CREF Investment Management's ISEE Position: Q2 2017 in Review

TIAA CREF Investment Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2017, closing a stake of 124,132 shares — an estimated $454K sold.

TIAA CREF Investment Management first reported a position in ISEE in Q4 2013 and held it in 14 quarters. The position peaked at $9.68M in Q4 2015. 77 funds tracked by Wall St. Rank hold ISEE as of Q2 2017.

  • TIAA CREF Investment Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • TIAA CREF Investment Management sold 124,132 IVERIC bio, Inc. Common Stock shares in Q2 2017, an estimated $454K.
  • TIAA CREF Investment Management first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 14 quarters.
  • TIAA CREF Investment Management's IVERIC bio, Inc. Common Stock position peaked at $9.68M in Q4 2015.
  • 77 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2017.

Based on TIAA CREF Investment Management's 13F filing for Q2 2017, filed 10 Aug 2017.